A Cross-Sectional Study Assessing Treatment Preference of People With Chronic Low Back Pain

Archives of Physical Medicine and Rehabilitation
Sara J FrancoisLinda R Van Dillen

Abstract

To assess treatment preference and attributes of 2 exercise-based treatments for people with chronic low back pain (LBP). Cross-sectional study. Academic research setting. Individuals (N=154) with chronic LBP. Not applicable. Participants completed a treatment preference assessment (TPA) measure that described 2 treatments for chronic LBP (strength and flexibility [SF] and motor skill training [MST]). Participants rated each treatment on 4 attributes: effectiveness, acceptability/logicality, suitability/appropriateness, and convenience. An overall score for each treatment was calculated as the mean of the 4 attribute ratings. The participants indicated either (1) no treatment preference or (2) preference for SF or MST. One hundred four participants (67.5%) had a treatment preference; of those, 95 (91.3%) preferred SF and 9 (8.7%) preferred MST. The SF preference group rated SF higher than MST overall and on all attributes (all Ps <.01, ds ranged from .48-1.07). The MST preference group did not rate the treatments differently overall or on any of the attributes (all Ps >.05, ds ranged from .43-.66). Convenience of SF (P=.05, d=.79) and effectiveness (d=1.20), acceptability/logicality (d=1.27), and suitability/appropriateness (d=...Continue Reading

Associated Clinical Trials

References

Aug 1, 1992·Pain·Michael Von KorffSamuel F Dworkin
Feb 4, 1988·The New England Journal of Medicine·J W Frymoyer
Sep 15, 1994·Spine·M Von Korff
Jun 6, 1998·BMJ : British Medical Journal·P R CroftA J Silman
Dec 22, 2000·Spine·J E Ware
Jan 13, 2004·Pain·Sarah Dianne LiddleJacqueline H Gracey
Nov 10, 2004·Journal of Occupational and Environmental Medicine·Robin S TurpinSean Nicholson
May 4, 2005·Annals of Internal Medicine·Jill A HaydenBart W Koes
May 4, 2005·Annals of Internal Medicine·Jill A HaydenGeorge Tomlinson
Jul 22, 2005·The Cochrane Database of Systematic Reviews·J A HaydenB W Koes
Oct 20, 2005·Journal of Epidemiology and Community Health·Ann Bowling, Gene Rowe
Sep 13, 2006·Worldviews on Evidence-based Nursing·Souraya SidaniJoyal Miranda
Jul 13, 2007·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Stephen May
Nov 4, 2008·BMJ : British Medical Journal·UNKNOWN Preference Collaborative Review Group
May 13, 2009·Research in Nursing & Health·Souraya SidaniJoyal Miranda
Jul 17, 2009·Behaviour Research and Therapy·Souraya SidaniPatricia Moritz
Nov 7, 2009·Physical Therapy·Leonardo O P CostaMatthew D Jennings
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Joanne L JordanNadine E Foster
Mar 17, 2010·Best Practice & Research. Clinical Rheumatology·Marienke van MiddelkoopMaurits W van Tulder
May 15, 2010·The Journal of Pain : Official Journal of the American Pain Society·Steven Z George, Michael E Robinson
Jan 5, 2011·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Tasha R StantonMark J Hancock
Oct 11, 2011·Lancet·Federico BalaguéChristine Cedraschi
Apr 3, 2012·The Journal of Orthopaedic and Sports Physical Therapy·Anthony DelittoUNKNOWN Orthopaedic Section of the American Physical Therapy Association
Nov 22, 2012·Medical Care Research and Review : MCRR·Cheryl RathertSuzanne Austin Boren
Apr 30, 2016·Spine·Bruno T SaragiottoLuciana G Macedo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.